Similarly, the co-upregulation of PD-1 and LAG-3 on exhausted TILs has been observed in resistant tumours, and dual PD-1/LAG-3 inhibition can reinvigorate these cells [197]. The gene discussed is LAG3; the disease is neoplasm.